Form 4: Arvinas CFO Andrew Saik Reports Stock and Option Awards

Andrew Saik, CFO of Arvinas, Inc., reports the acquisition of restricted stock units and stock options, indicating changes in his beneficial ownership of the company's securities.

Summary

• On February 13, 2025, Andrew Saik, the Chief Financial Officer of Arvinas, Inc., was granted 49,092 restricted stock units (RSUs) and an option to purchase 74,960 shares of common stock.
• The RSUs and options were granted under the company's 2018 Stock Incentive Plan.
• The RSUs vest over four years, with 25% vesting annually on February 13, starting in 2026 and continuing through 2029, contingent upon continued service.
• The stock options also vest over four years, with 1/4 vesting on February 13, 2026, and the remainder vesting in equal monthly installments until February 13, 2029, also contingent upon continued service.
• Saik also disposed of 110,501 shares of common stock.

Sentiment

Score: 7

Explanation: The document reflects standard executive compensation practices, suggesting a stable and incentivized management team. The sentiment is neutral to positive.

Positives

• The grant of RSUs and stock options to the CFO aligns his interests with those of the shareholders, incentivizing him to contribute to the company's long-term success.
• The vesting schedule encourages continued service and commitment from the CFO.

Future Outlook

The vesting schedules for the RSUs and stock options extend through February 13, 2029, indicating a long-term incentive structure for the CFO.

Industry Context

Stock option and RSU grants are common compensation practices in the biotechnology industry to attract and retain key executives and align their interests with shareholders.

Comparison to Industry Standards

• Stock option grants are a standard component of executive compensation packages in the biotechnology industry.
• Companies like Amgen, Gilead Sciences, and Biogen also utilize stock options and RSUs to incentivize their executives.
• The vesting schedules are typical for such grants, aligning with industry norms for retention and performance incentives.

Stakeholder Impact

• Shareholders may view the grants as a positive sign, indicating that the company is investing in its leadership.
• Employees may see the grants as a sign of the company's commitment to its executives.

Key Dates

Keywords

Arvinas, Saik, Stock Options, RSUs, Form 4, Beneficial Ownership, CFO, ARVN